Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-14 Sale |
2021-09-14 7:32 pm |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer |
954,053 | $38 | $36,254,014 | 0 (Indirect Direct) |
View |
| 2021-09-14 Sale |
2021-09-14 7:29 pm |
Translate Bio Inc. | TBIO | Burgess Paul D. Chief Operating Officer, CLO |
71,833 | $38 | $2,729,654 | 0 (Direct) |
View |
| 2021-09-14 Sale |
2021-09-14 7:26 pm |
Translate Bio Inc. | TBIO | Hughes Owen Director |
29,860 | $38 | $1,134,680 | 0 (Direct) |
View |
| 2021-09-14 Sale |
2021-09-14 7:23 pm |
Translate Bio Inc. | TBIO | FORMELA JEAN FRANCOIS Director |
2,055,063 | $38 | $78,092,394 | 0 (Indirect Direct) |
View |
| 2021-09-14 Purchase |
2021-09-14 09:59 am |
Translate Bio Inc. | TBIO | Sanofi 10% Owner |
71,983,597 | $38 | $2,735,376,686 | 75,668,031 (Direct) |
View |
| 2020-12-21 Sale |
2020-12-23 6:07 pm |
Translate Bio Inc. | TBIO | FORMELA JEAN FRANCOIS Director |
139,101 | $25.25 | $3,511,798 | 2,700,459 (Indirect) |
View |
| 2020-08-25 Sale |
2020-08-27 8:14 pm |
Translate Bio Inc. | TBIO | FORMELA JEAN FRANCOIS Director |
88,888 | $14.83 | $1,318,123 | 3,833,122 (Indirect) |
View |
| 2020-06-30 Sale |
2020-06-30 8:24 pm |
Translate Bio Inc. | TBIO | Shire Human Genetic Therapies Inc. TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
6,824,992 | $20.68 | $141,140,835 | 0 (Direct) |
View |
| 2020-06-26 Purchase |
2020-06-30 5:37 pm |
Translate Bio Inc. | TBIO | BAUPOST GROUP LLC Baupost Group GP L.L.C. KLARMAN SETH A 10% Owner |
500,000 | $22 | $11,000,000 | 18,044,239 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-14 Other(A) |
2021-09-16 5:43 pm |
N/A N/A |
Translate Bio Inc. | TBIO | BAUPOST GROUP LLC Baupost Group GP L.L.C. KLARMAN SETH A 10% Owner |
18,044,239 | $38 | 18,044,239 (Indirect) |
View |
| 2021-04-07 Exercise(A) |
2021-09-14 7:31 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer |
9,026 | $7.39 | 2,025,062 (Direct) |
View |
| 2021-04-07 Exercise(A) |
2021-09-14 7:31 pm |
N/A 2027-12-21 |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer |
9,026 | $0 | 2,025,062 (Direct) |
View |
Ownership |
2021-08-12 4:00 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Sanofi See Remarks below |
0 | $0 | 3,684,434 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 9:39 pm |
N/A 2031-06-15 |
Translate Bio Inc. | TBIO | FORMELA JEAN FRANCOIS Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-16 5:18 pm |
N/A 2031-06-15 |
Translate Bio Inc. | TBIO | Beckman Daniella Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-16 5:16 pm |
N/A 2031-06-15 |
Translate Bio Inc. | TBIO | Plenge Robert M Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-16 5:15 pm |
N/A 2031-06-15 |
Translate Bio Inc. | TBIO | Meyer Robert J. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-16 5:14 pm |
N/A 2031-06-15 |
Translate Bio Inc. | TBIO | Hughes Owen Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-16 5:13 pm |
N/A 2031-06-15 |
Translate Bio Inc. | TBIO | Demetri George Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-04-19 Option Award |
2021-04-20 4:49 pm |
N/A 2031-04-18 |
Translate Bio Inc. | TBIO | Smith Brendan Chief Financial Officer |
201,800 | $0 | 201,800 (Direct) |
View |
| 2021-04-07 Exercise |
2021-04-09 4:14 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer |
9,026 | $7.39 | 2,025,152 (Direct) |
View |
| 2021-04-07 Exercise |
2021-04-09 4:14 pm |
N/A 2027-12-21 |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer |
9,026 | $0 | 2,025,152 (Direct) |
View |
| 2021-03-22 Option Award |
2021-03-23 4:40 pm |
N/A 2031-03-22 |
Translate Bio Inc. | TBIO | Sutherland Everett Rand President |
300,000 | $0 | 300,000 (Direct) |
View |
| 2021-03-09 Option Award |
2021-03-09 8:27 pm |
N/A 2031-03-09 |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
325,000 | $0 | 325,000 (Direct) |
View |
| 2021-03-09 Option Award |
2021-03-09 8:26 pm |
N/A 2031-03-09 |
Translate Bio Inc. | TBIO | Wooster Richard Chief Scientific Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2021-03-09 Option Award |
2021-03-09 8:24 pm |
N/A 2031-03-09 |
Translate Bio Inc. | TBIO | Barbier Ann Chief Medical Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2021-03-09 Option Award |
2021-03-09 8:23 pm |
N/A 2031-03-09 |
Translate Bio Inc. | TBIO | Burgess Paul D. Chief Operating Officer, CLO |
90,000 | $0 | 90,000 (Direct) |
View |
| 2020-12-17 Ownership |
2021-02-16 4:12 pm |
N/A N/A |
Translate Bio Inc. | TBIO | LYNCH DANIEL Director |
100,000 | $0 | 221,825 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-14 7:59 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
5,638 | $7.39 | 2,115,058 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-14 7:59 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
1 | $8.34 | 2,115,058 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-14 7:59 pm |
N/A 2027-12-21 |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
5,639 | $0 | 2,115,058 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:30 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
53,004 | $7.39 | 2,115,058 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:30 pm |
N/A N/A |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
3 | $8.34 | 2,115,058 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:30 pm |
N/A 2027-12-21 |
Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. |
53,007 | $0 | 2,115,058 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-17 5:52 pm |
N/A 2030-06-15 |
Translate Bio Inc. | TBIO | LYNCH DANIEL Director |
18,900 | $0 | 18,900 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-17 5:51 pm |
N/A 2030-06-15 |
Translate Bio Inc. | TBIO | Beckman Daniella Director |
18,900 | $0 | 18,900 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-17 5:49 pm |
N/A 2030-06-15 |
Translate Bio Inc. | TBIO | FORMELA JEAN FRANCOIS Director |
18,900 | $0 | 18,900 (Direct) |
View |